CA 84953/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2003	1
2005	1
2006	1
2025	0

Page 1

Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.

Shedden KA, Kshirsagar MP, Schwartz DR, Wu R, Yu H, Misek DE, Hanash S, Katabuchi H, Ellenson LH, Fearon ER, Cho KR. Shedden KA, et al. Clin Cancer Res. 2005 Mar 15;11(6):2123-31. doi: 10.1158/1078-0432.CCR-04-2061. Clin Cancer Res. 2005. PMID: 15788657

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. van den Boom J, et al. Am J Pathol. 2003 Sep;163(3):1033-43. doi: 10.1016/S0002-9440(10)63463-3. Am J Pathol. 2003. PMID: 12937144 Free PMC article.

Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.

Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR. Hendrix ND, et al. Cancer Res. 2006 Feb 1;66(3):1354-62. doi: 10.1158/0008-5472.CAN-05-3694. Cancer Res. 2006. PMID: 16452189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year